Data as of Oct 28, 2026.

vsCompare their flowsaskIQ about these two fundsAsk the committee about these two funds
Across categories

SHV vs XBI: Differences, Returns & Fees

Share
Share on XDownload as PDF

Over the year to Oct 28, 2026, SHV returned +3.6% to XBI's +41.2%, and SHV charges 0.15% to XBI's 0.35%.

askIQ about this page

askIQ about SHV and XBI

Net assets on Oct 27, 2026: $21.7bn for iShares 0-1 Year Treasury Bond ETF and $10.3bn for State Street SPDR S&P Biotech ETF.

At a glance
+3.6%
SHV total return, 1 year
+41.2%
XBI total return, 1 year
0.15%
SHV expense ratio
0.35%
XBI expense ratio

Pair scorecard

SHV costs 0.20 points a year less; their one-year returns differ by 37.6 points; SHV is 2.1 times larger.

SHV vs XBI: Differences, Returns & Fees
MeasureSHVXBI
Return
Total return, 1 year+3.6%+41.2%
Drawdown
Below its all-time high8.9%, high on Feb 8, 2021
Benchmark
What it tracksICE Short US Treasury Securities IndexBiotech
Cost and size
Expense ratio0.15%0.35%
Net assets, as of Oct 27, 2026$21.7bn$10.3bn
Active share vs the S&P 50098%
Holdings
Holdings in common0%
In the S&P 500, by weight13%
Top ten holdings, share of the fund18%

Holdings in common uses holdings dated Oct 27, 2026. Method

What they share

0%

By the books each fund has filed, SHV and XBI hold 0% of their money in the same securities at the same weight. Holdings dated Oct 27, 2026.

0 half 100%

half

0% in common

Positions both hold · largest shared weight first SHV XBI
Only in one fund ↓
Only in SHV
TREASURY BILL 4.98%
TREASURY BILL 4.17%
TREASURY BILL 3.90%
TREASURY BILL 3.72%
TREASURY BILL 3.58%
TREASURY BILL 3.48%
TREASURY BILL 3.35%
TREASURY BILL 3.31%
Only in XBI
MODERNA INC 2.24%
TWIST BIOSCIENCE CORP 1.86%
NATERA INC 1.82%
BIOGEN INC 1.75%
HALOZYME THERAPEUTICS INC 1.75%
UNITED THERAPEUTICS CORP 1.71%
AMGEN INC 1.68%
ABBVIE INC 1.67%
Check overlap with more funds →

Side by side

SHV iShares 0-1 Year Treasury Bond ETF XBI State Street SPDR S&P Biotech ETF
Where it sits Bond ETF Thematic ETF
What it is Tracks an index of 0-1 Year Treasury Bond Biotech
Total return, 1 year +3.6% +41.2%
Expense ratio 0.15% 0.35%
Holdings 66 165
Net assets, as of Oct 27, 2026 $21.7bn $10.3bn

SHV and XBI on the fields both publish, as of Oct 28, 2026. Source: ETFIQ.

Alert

SHV and XBI flows, by email on Sundays.

One-click unsubscribe. See Privacy.

About each fund
SHV

SHV tracks an index of 0-1 Year Treasury Bond. Over the year to Oct 28, 2026 it returned +3.6% with distributions reinvested. The prospectus expense ratio is 0.15% a year.

XBI

By weight, 13% of XBI's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 98%. The top ten holdings are 18% of the fund across 165 positions, as published by its issuer for Oct 27, 2026. Over the year to Oct 28, 2026 the fund returned +41.2% with distributions reinvested. It sits 8.9% below its all-time high of Feb 8, 2021.

Questions people ask

Are SHV and XBI in the same category?
SHV is a bond ETF and XBI is a thematic ETF, so they do different jobs. The table compares what both publish: return, cost and holdings.
Which returned more over the last year, SHV or XBI?
In the year to Oct 28, 2026, with distributions reinvested, SHV returned +3.6% and XBI +41.2%.
Which is cheaper, SHV or XBI?
SHV is cheaper, by 0.20 percentage points a year. That is about $20 on $10,000 held for a year. Fees come from each fund's prospectus.
Other comparisons
Cite this pageCitation, APA and Markdown

ETFIQ, SHV against XBI, data as of Oct 28, 2026. https://etfiq.com/compare/any/shv-vs-xbi

Open data →

Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.